On March 31, 2026, Symrise announced the launch of Cellexora MD, a new cosmetic ingredient based on plant-based true exosomes, to its Care & Wellness portfolio. This ingredient is made from upcycled organic apple side streams in Italy, making it a natural-origin ingredient with exceptional stability and traceability.
According to the company’s press release, Cellexora MD allows manufacturers to support deep skin regeneration and long-term vitality while meeting growing consumer demand for efficacy, transparency and sustainability. The plant-derived extracellular vesicles act as biological messengers that facilitate cell-to-cell communication. The ingredient uses targeted interactions with keratinocytes, fibroblasts and macrophages to address the root causes of skin aging and support multi-layer protection.
“These plant-derived exosomes bring nature’s biological intelligence into premium skincare,” said Nathalie Chevrot, global skin care category director at Symrise. “Cellexora MD helps strengthen long-term skin health, vitality and biological function over time. It adds a powerful component to Symrise’s line-up of premium cosmetic ingredients. As consumers increasingly seek true effective skincare beyond correcting visible signs of aging, this innovation helps our customers lead the shift toward health span-driven skincare and advanced skin regeneration.”
Cellexora MD is an odorless white powder with 100% natural origin. Further, the ingredient has high water solubility to provide formulation flexibility and seamless integration into product application. The company’s clinical data show a reduction in visible signs of aging within 30 days of use.
Symrise will present Cellexora MD at in-cosmetics Global 2026 in Paris, France.
